Research advances in microneme protein 3 of Toxoplasma gondii
© Wang and Yin. 2015
Received: 7 April 2015
Accepted: 9 July 2015
Published: 22 July 2015
Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite. It has extensive host populations and is prevalent globally; T. gondii infection can cause a zoonotic parasitic disease. Microneme protein 3 (MIC3) is a secreted protein that is expressed in all stages of the T. gondii life cycle. It has strong immunoreactivity and plays an important role in the recognition, adhesion and invasion of host cells by T. gondii. This article reviews the molecular structure of MIC3, its role in the invasion of host cells by parasites, its relationship with parasite virulence, and its induction of immune protection to lay a solid foundation for an in-depth study of potential diagnostic agents and vaccines for preventing toxoplasmosis.
KeywordsToxoplasmosis Microneme protein 3 Function Diagnostic agents and vaccines
Properties of Toxoplasma microneme proteins
Major putative functions
Transport/folding of MIC4 and MIC6
Binding to host cells
1 Integrin, 5 TSRs, and 1 TM
Transport M2AP and adhesion
1 CBL and 5 EGF
Parvulin-like PPIase motif
Suppressing TgSUB1 activity
5 EGF-like and 1 TM
1 CBL, 10 EGF-like, and 1 TM
3 EGF and 1 TM
31 EGF, 4 TSRs, and 1 TM
Inhibiting secretion of the rhoptries
Beta and coil
Transport/folding of MIC2
Subtilase and GPI
1 thrombomodulin EGF, 2 TSRs
Trafficking of the protein
Cytolysis and parasite egress
Molecular characteristics of MIC3
The MIC3 complex of T. gondii
Regulatory mechanisms of MIC secretion
Micronemes are secretion organs that are located at the apical ends of parasites. MICs are synthesized at the rough ER, are transported to micronemes through the Golgi apparatus and are secreted outside the body. It is generally accepted that the secretion of T. gondii MICs is only regulated by the intracellular calcium ion levels in parasites . Under normal conditions, T. gondii tachyzoites secret MICs at a very low level; when the intracellular calcium ion level increases, the secretion of MICs can increase 10-100-fold . The imbalance of calcium ions will induce the deregulation of MIC secretion. Some reagents that can neutralize intracellular calcium ions can strongly inhibit MIC secretion by micronemes. The regulation of MIC secretion by calcium ions in parasites does not require the participation of exogenous calcium ions [40, 41]. Additionally, through the research of microneme secretion based on levels of MIC5, Carey et al. extrapolated that there could be two types of micronemes: one that discharges rapidly in response to elevated intracellular calcium, and one that discharges constitutively . Further larger trials are needed to determine whether two types of micronemes exist.
MIC3 protein folding and hydrolysis
Newly synthesized proteins require structural modification at the ER. Misfolded or incompletely folded oligomeric complexes will be retained at the ER and will finally be degraded. There are some molecular chaperones and folding enzymes at the ER; they can assist the correct folding and assembly of proteins and can provide anchor points for retained immature proteins . The retention functions of ER rely on different folding sensors; the N-glycans on the surface of misfolded proteins can be recognized by calreticulin and calnexin. The exposed cysteine residue plays a role in thiol-mediated protein retention; under this condition, thiol oxidoreductase on the ER membrane is associated with the retention of unassembled proteins. MIC3, MIC4, and MIC6 are rich in cysteine residues . When the early peptides are transported to the ER, cysteine residues form disulfide conjugates to perform correct folding. Incorrectly folded proteins may form aggregates and cannot be correctly transported.
The hydrolysis processing of MICs is very common and is necessary for the smooth completion of the invasion process, which mainly occurs in 2 stages. The first stage occurs at the secretory pathway, that is, transportation to the micronemes through the Golgi apparatus after synthesis by the rough ER. The hydrolysis process at this stage is associated with the formation of specific complexes, correct targeting of complexes to organelles, and masking of enzyme active sites. MIC3, MIC5, MIC6, and M2AP are actively involved in this stage [20, 44]. The second stage occurs after extracellular secretion and discharge during the process of the invasion of host cells by T. gondii. The processing at the second stage is helpful for the completion of complex separation, host cell adhesion, and invasion of parasites. For example, the protein processing of MIC2, MIC4, MIC6, and MIC8 induce the rapid release of MICs on the cell surface, which is a key step for completion of the cell invasion. If processing is lacking, secreted MICs can establish persistent, stable bridges on the surface of host cells and parasites, thus interfering with the newly formed correct closure of parasitic vesicles and inhibiting the proliferation of parasites in vacuoles. Studies showed that unprocessed MICs increased adhesion to host cells; however, the invaded parasites decreased. Many MICs are produced as a pre-protein form and go through proteolytic processing during the secretion pathway and transport process. When crossing the Golgi apparatus, the first EGF-like domain of MIC6 is removed ; the function of this process is unknown, but this step does not affect the microneme targeting ability of the interaction between MIC6 and MIC1 . MIC3 is also initially synthesized as a 40-kDa dimeric precursor, which then becomes a 38-kDa product through proteolysis before reaching the micronemes . The removal of the leader peptides of MICs is necessary for interaction with the host cells . The enzymes that hydrolyze T. gondii MICs have not been completely clarified.
The function of MIC3 in the process of invasion of the host cells by parasites
T. gondii can invade almost all nucleated cells, indicating that there are multiple “receptor-ligand” interactions between parasites and host cells. Although the mechanisms underlying the invasion of host cells by T. gondii have not been completely clarified, current studies indicate that T. gondii actively invades cells, unlike the endocytosis processes of infection used by bacteria and viruses. When T. gondii contacts host cells, parasites first push the conoid outside the body, and then, micronemes discharge a large amount of MICs through the conoid. MICs interact with corresponding receptors on the host cell membrane and are distributed on the surface of parasites. The front end of parasites, which interacts with cells, forms a moving junction ; next, the actin-myosin system exerts its function. At the moving junction of parasites, MICs move from the front end of parasites to the rear end of parasites through the force produced by actin proteins and are finally hydrolyzed; parasites invade cells through the moving junctions [8, 11, 35, 47, 48]. Therefore, MICs, including MIC3, play a bridging role between parasites and host cells.
It has been shown that mic1 knockout alone affected the invasion of HFF cells by T. gondii and that mic3 knockout alone did not affect the invasion; the results of a mic3/mic1 double knockout did not show significant differences from the mic1 knockout. These results indicate that these 2 proteins did not have synergistic effects on T. gondii invasion . These results contradict those showing that MIC3 was secreted outside cells during the invasion process of T. gondii and adhered to a variety of cells, including fibroblasts, macrophages, and epithelial cells. Cérède et al.  proposed that MICs may contain a large number of components and that different components could recognize the same receptor. For example, during the infection of HFF cells after mic3 knockout, other MICs would interact with the cell surface receptors; however, MIC3 may be indispensable for the infection of other cell types. In addition, during the invasion process, parasites may have alternative invasion routes. Furthermore, in vitro culture and natural infection methods may display differences; in in vitro culture, the disappearance of one gene function may be compensated for by other MICs or may up-reregulate the secretion of other MICs to allow for normal invasion; however, this gene may be very important in natural infection conditions.
The association between MIC3 and the virulence of parasites
MICs contain a series of conserved adhesion domains, and some domains have been confirmed to be associated with parasite invasion . Following infection of HFF cells after the T. gondii mic3 gene was knocked out, the adhesion characteristics were not affected, but the parasite virulence significantly reduced. T. gondii with gene disruption of mic1 or mic3 were inoculated into mice, and all of the inoculated mice died after 9–22 days of inoculation; mice in the control group without gene knockout all died within 7–10 days. These results indicated that after T. gondii mic1 and mic3 were separately knocked out, the virulence of T. gondii only decreased slightly. T. gondii with both the mic1 and mic3 genes knocked out were inoculated into mice, and the results showed that only 1 mouse among the 10 mice died and that the death time of mouse was delayed by 10 days compared to that of the control group. In addition, the dose was adjusted and inoculated into mice to cause the death of all mice on day 9; comparison of lethal doses with the control group showed that the inoculation amount of the double gene knockout T gondii was 2 × 103 parasite/mouse and that the dose in the control group was lower than 20 parasite/mouse. These results indicate that knockout of the mic1 and mic3 genes together significantly reduced the parasite virulence and confirmed that MIC1 and MIC3 had synergistic effects on the parasite virulence .
MIC3 has a very strong affinity for host cells, which is closely associated with its CBL domain . The common sequences of CBL domain contain 8 disulfide bond-linked cysteine residues and several highly conserved aromatic residues. BHK-21 cells were transfected with the recombinant MIC3 plasmid, and the location of the expression product was detected. The results showed that the expression product of the recombinant MIC3 with CBL domain knockout was in the supernatant, whereas the expression product of the recombinant MIC3 without CBL domain knockout was on the cell surface. These results indicate that the CBL domain of T. gondii MIC3 is very important for cell adhesion.
In CBL domain, Cysteines determine the protein conformation, and aromatic residues react with N-acetylglucosamine. Transfection of BHK-21 cells with the recombinant MIC3 plasmid in which all the cysteine residues in CBL domain were replaced by glycine residues resulted in insufficient secretion and accumulation of the expression product, indicating that cysteine residues determine the protein conformation. In the aromatic residue replacement experiment, the F121A and Y141A mutants influenced the protein expression in BHK-21 cells; however, the adhesion characteristics of these two residues could not be confirmed. The transfection experiments of the other recombinants (Y96A, F97A, P103A, W126A, F128A, and Y135A) proved that only the expression products of the W126A and F128A mutants were in the supernatant and did not bind to the surface of transfected BHK-21 cells, indicating that the replacement of W126 or F128 alone resulted in the complete loss of adhesion function and that they were closely associated with the interaction with cell surface receptors and adhesion. The replacement of tryptophan at position 126 with glycine (W126A) and the replacement of phenylalanine at position 128 with glycine (F128A) in the CBL domain of MIC3 caused a significant reduction of virulence of the mutant strains. These studies indicated that the MIC3 CBL domain that is associated with adhesion is very important for the virulence of parasites .
Induction of immune protection by MIC3
MIC3 plays important roles in the invasion process of T. gondii; it has very strong immunogenicity and can stimulate the production of corresponding humoral immunity and cellular immunity in the body. Therefore, in studies of vaccines against T. gondii infection, MICs have received much attention. Vaccines based on MIC3 include live attenuated vaccines, subunit vaccines, and DNA vaccines.
Gene deletion attenuated vaccine based on MIC3 of T. gondii
Some scholars have performed studies on live attenuated vaccines by knocking out double virulence genes of parasites. A mutant strain of T. gondii (RH strain) lacking the mic1 and mic3 genes (Mic1-3KO) tachyzoites to immunize mice and that showed mice could produce a strong protective function [14, 49]; not only could the mother defend against T. gondii infection but also vertical transmission could be effectively prevented . Of note, the MIC1-3KO attenuated strain induced good immune effects in murine models and also had ideal immune effects in large animal models. Subcutaneously immunized ewes with MIC1-3KO tachyzoites showed that IgG antibodies occurred in serum samples. Ewes at mid-gestation were challenged with the PRU strain of T. gondii, and the results showed that pregnant ewes in the vaccinated group only had a slight febrile response, whereas unvaccinated ewes produced a more severe, characteristic febrile response of a longer duration; all unvaccinated ewes aborted. The survival rates of newborn lambs in the vaccinated group were 62 %, 91 %, and 64 %, and there were no clinical signs of infection. A dose of 105 MIC1-3KO tachyzoites was sufficient to induce protective immune responses and had very good preventive function against toxoplasmosis-induced abortion in ewes . At present the strain MIC1-3KO is the main product of a French innovative company (VitamFero SA) and it is called "Toxo KO" vaccine. "Toxo KO" vaccine represents a new generation of live and attenuated vaccines obtained through the deletion of 2 genes of virulence, and the risk of reversion to virulence is totally eliminated (http://www.vitamfero.com/en/technology.html). "Toxo KO" vaccine will play an important role in preventing ovine and feline toxoplasmosis.
Subunit vaccines based on MIC3 of T. gondii
Subunit vaccines are vaccines developed using DNA recombinant technology to introduce antigenic genes of pathogens into prokaryotic or eukaryotic expression systems to express the corresponding antigenic proteins; these vaccines have the advantages of easy preparation of antigenic proteins and high yields. Nie et al.  vaccinated BALB/c mice with recombinant pseudorabies virus (PRV) expressing MIC3 (rPRV-MIC3), and the results showed that rPRV-MIC3 could induce significant humoral and Th1 cellular immune responses. After being challenged by the T. gondii RH strain at a lethal dose (100 tachyzoites), the survival rate of immunized mice was 50 %, and no protection was found in control groups. These results indicated that rMIC3 had better immunogenicity and could produce a certain protective immunity, which provided reliable bases for the development of MIC3 subunit vaccines for T. gondii. However, current subunit vaccines still have issues such as insufficient immunogenicity and protective function and too short of a persistent time of the immune responses.
Nucleic acid vaccines based on MIC3 of T. gondii
T. gondii belongs to strictly intracellular parasitic protozoa. In induced immune responses in the body, cellular immunity is more important than humoral immunity; especially in the acute infection phase, cellular immunity usually plays a decisive role. DNA vaccines express corresponding antigenic proteins in host cells and comprehensively induce specific immune responses in the body. Compared to other vaccines, DNA vaccines have the potential advantages of safety, stability, convenience, high efficiency, and persistent immunity. Ismael et al. used the pMIC3i plasmid encoding the immature MIC3 protein to intramuscularly inoculate CBA/J mice. Immunized mice all produced high titers of IgG2a type anti-MIC3 immunoglobulin as well as IFN-γ and IL-2. Inoculation of mice with the pGM-CSF plasmid encoding the granulocyte-macrophage colony-stimulating factor gene and the pMIC3i plasmid together showed that immunized mice produced stronger humoral immune responses. Oral administration of cysts of the 76 K strain of T. gondii into immunized mice showed that the number of cysts detected in the brain was significantly lower than that in control mice . Fang et al.  used the “suicidal” pSCA1 vector to construct a T. gondii suicidal DNA vaccine pSCA/MIC3. As conventional DNA vaccine pcDNA/MIC3, suicidal DNA vaccine pSCA/MIC3 also provides favourable efficacy. Meantime, based on the alphavirus replicon, suicidal DNA vaccines leads eventually to apoptosis of the transfected cells, which is particularly important in alleviating the concerns of potential integration and cell transformation generated by the use of conventional DNA vaccines, so it could improve safety of the conventional DNA vector. In this case, the design of vaccines against T. gondii based on suicidal DNA approach is feasible and effective. CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection [54, 55], both Lectin-like and EGF-like domains of MIC3 conferred protection . Of note, the MIC3 DNA vaccine induced good immune effects in large animal models (sheep) .
Although monovalent DNA vaccines can induce a very strong immune reaction in the body against T. gondii infection, the preventive function is not comprehensive, and the immune effect is not ideal . Hence, in the course of researching T. gondii vaccines, a consensus to develop multivalent vaccines that contain a combination of several antigens and target different developmental stages has been reached with the aim of overcoming the drawback of the monovalent candidate vaccines . Qu et al.  immunized mice with the constructed composite DNA vaccine ZJ111/PSAG1-MIC3, and the results showed that mice could reduce stronger humoral and Th1-type cellular immunity than those in the control group (pSAG1, pMIC3, and pcDNA3.1). After being challenged by the T. gondii RH strain at a lethal dose for 12 days, the survival rate of mice was still above 20 %, whereas mice in the control group all died within 5–6 days. Therefore, compared to monovalent DNA vaccines, multivalent composite DNA vaccines can produce better protective immunity. Some other studies also support the view that the introduction of multiantigenic DNA vaccine is more powerful and efficient than single-gene vaccine, and deserves further evaluation and development [60, 61]. The multiantigenic DNA immunization might be an important approach to achieve an effective vaccine against T. gondii.
Cytokines are excellent adjuvants and can significantly enhance the immune effects of gene vaccines. IFN-γ is an immune upregulation factor that plays a leading role. During the process of resisting T. gondii infection by immune cell, IFN-γ plays an important immune regulation role . The pcMIC3 eukaryotic expression plasmid encoding the T. gondii MIC3 and the pcIFN-γ eukaryotic expression plasmid encoding IFN-γ were mixed together at 100 μg each and were then intramuscularly injected into BALB/c mice 3 times at intervals of 2 weeks. The results showed that mice could effectively defend the challenge of a small dose of a strong virulent strain of T. gondii, indicating that the recombinant plasmids encoding the T. gondii MIC3 and IFN-γ had excellent immunogenicity to induce strong humoral immunity and cellular immunity . Collectively, these results demonstrated that MIC3 is considered a very promising candidate molecule for the development of vaccines against toxoplasmosis.
Taken together, studies have indicated that immune protection of MIC3 is influenced by multiple factors. Adjuvants play an important role in the efficacy of immunizations. It is the general consensus of opinion that a type-1 response, particularly associated with CD8+ T cells producing IFN-γ, is the major mediator of immunity against T. gondii infection. Other important factors in immunization experiments are the selection of animal model (species/strain) and the selection of T. gondii strain. In general, as mice are normally susceptible to T. gondii infection, parasite strains with low virulence or low doses of virulent strains may be preferentially selected by some researchers . In some studies of immunization, oral challenges were made with cystogenic strains . It is important to point out that unnatural routes of infection may be key determinants of mouse survival.
Studies on diagnostic reagents based on MIC3 of T. gondii
MIC3 is expressed at all stages of the life cycle of T. gondii. Therefore, MIC3 is not only an important candidate molecule for vaccines but also a very promising candidate molecule for the diagnosis of toxoplasmosis. Immunological diagnostic methods based on MIC3 of T. gondii include the indirect fluorescent antibody test (IFAT), latex agglutination test (LAT), enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and so on. Jiang et al.  used recombinant T. gondii MIC3 (rMIC3) as an antigen to establish a LAT; there was no cross-reactivity with the standard positive sera of other pathogens, such as classical swine fever virus and foot and mouth disease virus, but there was a strong agglutination reaction with T. gondii antibody-positive serum samples from pigs. In addition, compared to the ELISA method using rSAG1 as the antigen, the coincidence rate of sera that tested positive using these two methods was 92.8 %, and this LAT could detect specific T. gondii antibodies in all experimental piglets infected with T. gondii tachyzoites at 8 to 42 days after infection. Beghetto et al.  used rMIC3 as an antigen to establish an immunoglobulin G avidity assay, and this assay could detect low-avidity IgG antibodies exclusively in sera collected within 2 months after primary infection. The presence of low-avidity IgG antibodies against rMIC3 antigen can be used to determine the point of infection with T. gondii within a 2-month time frame after infection. Furthermore, another research group also demonstrated that particular peptides from MIC3 (MIC3–282:GVEVTLAEKCEKEFGI; MIC3–191:SKRGNAKCGPNGTCIV) were recognized with a significantly higher intensity by sera from acutely infected patients than by sera from latently infected patients, and that these peptides may be candidates for a promising peptide panel for the diagnosis of acute toxoplasmosis in humans . These results indicated that MIC3 is a very good marker for diagnosing recently acquired infections and has potential clinical usefulness for diagnosing the acute phase of T. gondii infection during pregnancy. Furthermore, the mic3 gene is also a target for molecular diagnosis of toxoplasmosis. Du et al. [69, 70] used the T. gondii mic3 gene as a target gene to design specific primers to establish a loop-mediated isothermal amplification (LAMP) assay to detect T. gondii in soil. This method had high sensitivity and could detect 5 T. gondii oocysts in 0.5 g of soil, providing a rapid, sensitive, and specific molecular detection method for diagnosis of toxoplasmosis.
Ethical approval was obtained from the Ethical Committee of the Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences.
MIC3 is a very important protein adhesion factor secreted by T. gondii that is expressed at the tachyzoite, bradyzoite, and sporozoite stages. It is closely associated with the interaction with host cells and parasites, plays important roles in the early stage of host cell invasion by parasites and is a highly promising candidate factor for vaccine development and diagnosis of toxoplasmosis. Currently, studies on MICs have made great progress, and their structures and functions are becoming clear. The EGF-like domain of MIC3 may have protein adhesion and signal recognition functions during the process of invasion of host cells by T. gondii. The correct folding, proteolysis, and expression time of these domains also strictly affect the function of MIC3 in parasites. Therefore, the use of methods such as bioinformatics analysis, fluorescence labeling, establishment of overexpression parasites, gene knockout, gene chips, and high-throughput genome sequencing to study the functions of MIC3 may yield further breakthroughs in parasite-host interaction, signal recognition, and new functions of MIC3.
This study was supported by grants from the Natural Science Foundation of Gansu Province, China (145RJZA234) and NBCITS, MOA (CARS-38).
- Paredes-Santos TC, de Souza W, Attias M. Dynamics and 3D organization of secretory organelles of Toxoplasma gondii. J Struct Biol. 2012;177:420–30.PubMedView ArticleGoogle Scholar
- Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56:296–305.PubMedView ArticleGoogle Scholar
- Raizman RE, Neva FA. Detection of circulating antigen in acute experimental infections with Toxoplasma gondii. Infect Dis. 1975;132:44–8.View ArticleGoogle Scholar
- Mwambe B, Mshana SE, Kidenya BR, Massinde AN, Mazigo HD, Michael D, et al. Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza. Tanzania Parasites Vectors. 2013;6:222.PubMedView ArticleGoogle Scholar
- Mévélec MN, Bout D, Desolme B, Marchand H, Magné R, Bruneel O, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine. 2005;23:4489–99.PubMedView ArticleGoogle Scholar
- Dowse T, Soldati D. Host cell invasion by the apicomplexans: the significance of microneme protein proteolysis. Curr Opin Microbiol. 2004;7:388–96.PubMedView ArticleGoogle Scholar
- Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 1996;84:933–9.PubMedView ArticleGoogle Scholar
- Dobrowolski JM, Carruthers VB, Sibley LD. Participation of myosin in gliding motility and host cell invasion by Toxoplasma gondii. Mol Microbiol. 1997;26:163–73.PubMedView ArticleGoogle Scholar
- Meissner M, Schlüter D, Soldati D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science. 2002;298:837–40.PubMedView ArticleGoogle Scholar
- Barragan A, Sibley LD. Migration of Toxoplasma gondii across biological barriers. Trends Microbiol. 2003;11:426–30.PubMedView ArticleGoogle Scholar
- Soldati D, Meissner M. Toxoplasma as a novel system for motility. Curt opion cell boil. 2004;16:32–40.View ArticleGoogle Scholar
- Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Biol. 1997;73:114–23.PubMedGoogle Scholar
- Meissner M, Reiss M, Viebig N, Carruthers VB, Toursel C, Tomavo S, et al. A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters. J Cell Sci. 2002;115:563–74.PubMedGoogle Scholar
- Cérède O, Dubremetz JF, Soête M, Deslée D, Vial H, Bout D, et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med. 2005;201:453–63.PubMed CentralPubMedView ArticleGoogle Scholar
- Saouros S, Edwards-Jones B, Reiss M, Sawmynaden K, Cota E, Simpson P, et al. A novel galectin-like domain from Toxoplasma gondii micronemal protein 1 assists the folding, assemblymand transport of a cell-adhesion complex. J Biol Chem. 2005;280:38583–91.PubMedView ArticleGoogle Scholar
- Wan KL, Carruthers VB, Sibley LD, Ajioka JW. Molecular characterisation of an expressed sequence tag locus of Toxoplasma gondii encoding the micronemal protein MIC2. Mol Biochem Parasitol. 1997;84:203–14.PubMedView ArticleGoogle Scholar
- Jewett TJ, Sibley LD. The Toxoplasma proteins MIC2 and M2AP form a hexameric complex necessary for intracellular survival. J Biol Chem. 2004;279:9362–9.PubMedView ArticleGoogle Scholar
- Garcia-Reguet N, Lebrun M, Fourmaux MN, Mercereau-Puijalon O, Mann T, Beckers CJ, et al. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesion that binds to both the surface of the host cells and the surface of the parasite. Cell Microbio. 2000;2:353–64.View ArticleGoogle Scholar
- Brecht S, Carruthers VB, Ferguson DJ, Giddings OK, Wang G, Jakle U, et al. The Toxoplasma micronemal protein MIC4 is an adhesin composed of six conserved apple domains. J Biol Chem. 2001;276:4119–27.PubMedView ArticleGoogle Scholar
- Reiss M, Viebig N, Brecht S, Fourmaux MN, Soete M, Di Cristina M, et al. Identification and characterization of an escorter for two secretory adhesions in Toxoplasma gondii. J cell boil. 2001;152:563–78.View ArticleGoogle Scholar
- Brydges SD, Sherman GD, Nockemann S, Loyens A, Däubener W, Dubremetz JF, et al. Molecular characterization of TgMIC5, a proteolytically processed antigen secreted from the micronemes of Toxoplasma gondii. Mol Biochem Parasitol. 2000;111:51–66.PubMedView ArticleGoogle Scholar
- Hoff EF, Cook SH, Sherman GD, Harper JM, Ferguson DJ, Dubremetz JF, et al. Toxoplasma gondii: molecular cloning and characterization of a novel 18-kDa secretory antigen, TgMIC10. Exp Parasitol. 2001;97:77–88.PubMedView ArticleGoogle Scholar
- Harper JM, Zhou XW, Pszenny V, Kafsack BF, Carruthers VB. The novel coccidian micronemal protein MIC11 undergoes proteolytic maturation by sequential cleavage to remove an internal propeptide. Int J Parasitol. 2004;34:1047–58.PubMedView ArticleGoogle Scholar
- Opitz C, Di Cristina M, Reiss M, Ruppert T, Crisanti A, Soldati D. Intramembrane cleavage of microneme proteins at the surface of the apicom plexan parasite Toxoplasma gondii. EMBO J. 2002;21:1577–85.PubMed CentralPubMedView ArticleGoogle Scholar
- Mital J, Meissner M, Soldati D, Ward GE. Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion. Mol Biol Cell. 2005;16:4341–9.PubMed CentralPubMedView ArticleGoogle Scholar
- Rabenau KE, Sohrabi A, Tripathy A, Reitter C, Ajioka JW, Tomley FM, et al. TgM2AP participates in Toxoplasma gondii invasion of host cells and is tightly associated with the adhesive protein TgMIC2. Mol Microbiol. 2001;41:537–47.PubMedView ArticleGoogle Scholar
- Huynh MH, Rabenau KE, Harper JM, Beatty WL, Sibley LD, Carruthers VB. Rapid invasion of host cells by Toxoplasma requires secretion of the MIC2-M2AP adhesive protein complex. EMBO J. 2003;22:2082–90.PubMed CentralPubMedView ArticleGoogle Scholar
- Miller SA, Binder EM, Blackman MJ, Carruthers VB, Kim K. A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. J Biol Chem. 2001;276:45341–8.PubMedView ArticleGoogle Scholar
- Brossier F, Jewett TJ, Sibley LD, Urban S. Aspatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proc Natl Acad Sci USA. 2005;102:4146–51.PubMed CentralPubMedView ArticleGoogle Scholar
- Dowse TJ, Soldati D. Rhomboid-like proteins in Apicomplexa: phylogeny and nomenclature. Trends Parasitol. 2005;21:254–8.PubMedView ArticleGoogle Scholar
- Huynh MH, Boulanger MJ, Carruthers VB. A conserved apicomplexan microneme protein contributes to Toxoplasma gondii invasion and virulence. Infect Immun. 2014;82:4358–68.PubMed CentralPubMedView ArticleGoogle Scholar
- Kafsack BF, Pena JD, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB. Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells. Science. 2009;323:530–3.PubMed CentralPubMedView ArticleGoogle Scholar
- Roiko MS, Carruthers VB. Functional dissection of Toxoplasma gondii perforin-like protein 1 reveals a dual domain mode of membrane binding for cytolysis and parasite egress. J Biol Chem. 2013;288:8712–25.PubMed CentralPubMedView ArticleGoogle Scholar
- Laliberté J, Carruthers VB. Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemes. Mol Biochem Parasitol. 2011;177:49–56.PubMed CentralPubMedView ArticleGoogle Scholar
- Cèrède O, Dubremetz JF, Bout D, Lebrun M. The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesion. EMBO J. 2002;21:2526–36.PubMed CentralPubMedView ArticleGoogle Scholar
- Soldati D, Dubremetz JF, Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol. 2001;31:1293–302.PubMedView ArticleGoogle Scholar
- Carruthers VB, Sherman GD, Sibley LD. The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases. J Biol Chem. 2000;275:14346–53.PubMedView ArticleGoogle Scholar
- Kim K. Role of proteases in host cell invasion by Toxoplasma gondii and other Apicomplexa. Acta Trop. 2004;91:69–81.PubMedView ArticleGoogle Scholar
- Carruthers VB, Diggings OK, Sibley LD. Secretion of micronemal proteins is associated with Toxoplasma invasion of host cells. Cell Microbiol. 1999;1:225–35.PubMedView ArticleGoogle Scholar
- Moudy R, Manning TJ, Beckers CJ. The loss of cytoplasmic potassium upon host cell breakdown triggers egress of Toxoplasma gondii. J Biol Chem. 2001;276:41492–501.PubMedView ArticleGoogle Scholar
- Lovett JL, Sibley LD. Intracellular calcium stores in Toxoplasma gondii govern invasion of host cell. Cell Sci. 2003;116:3009–16.View ArticleGoogle Scholar
- Carey KL, Westwood NJ, Mitchison TJ, Ward GE. A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii. Proc Natl Acad Sci USA. 2004;101:7433–8.PubMed CentralPubMedView ArticleGoogle Scholar
- Harper JM, Huynh MH, Coppens I, Parussini F, Moreno S, Carruthers VB. A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion of the TgMIC2-M2AP invasion complex. Mol Biol Cell. 2006;17:4551–63.PubMed CentralPubMedView ArticleGoogle Scholar
- Carruthers VB, Håkansson S, Giddings OK, Sibley LD. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun. 2000;68:4005–11.PubMed CentralPubMedView ArticleGoogle Scholar
- Achbarou A, Mercereau-Puijalon O, Autheman JM, Fortier B, Camus D, Dubremetz JF. Characterization of microneme proteins of Toxoplasma gondii. Mol Biochem Parasitol. 1991;47:223–33.PubMedView ArticleGoogle Scholar
- El Hajj H, Papoin J, Cérède O, Garcia-Réguet N, Soête M, Dubremetz JF, et al. Molecular signals in the trafficking of Toxoplasma gondii protein MIC3 to the micronemes. Eukaryot Cell. 2008;7:1019–28.PubMed CentralPubMedView ArticleGoogle Scholar
- Matthiesen SH, Shenoy SM, Kim K, Singer RH, Satir BH. Role of the parafusion orthologue. PRP1. in microneme exocytosis and cell invasion in Toxoplasma gondii. Cell Microbiol. 2003;5:613–24.PubMedView ArticleGoogle Scholar
- Suss-Toby E, Zimmerberg J, Ward GE. Toxoplasma invasion: the parasitophorous vacuole is formed from host cell plasma membrane and pinches of via a fission pore. Proc Natl Acad Sci USA. 1996;93:84l3–8.View ArticleGoogle Scholar
- Ismael AB, Dimier-Poisson I, Lebrun M, Dubremetz JF, Bout D, Mevelec MN. Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice. J Infect Dis. 2006;194:1176–83.PubMedView ArticleGoogle Scholar
- Mévélec MN, Ducournau C, Bassuny Ismael A, Olivier M, Sèche E, Lebrun M, et al. Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep. Vet Res. 2010;41:49.PubMed CentralPubMedView ArticleGoogle Scholar
- Nie H, Fang R, Xiong BQ, Wang LX, Hu M, Zhou YQ, et al. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins. Vet Parasitol. 2011;181:215–21.PubMedView ArticleGoogle Scholar
- Ismael AB, Sekkai D, Collin C, Bout D, Mévélec MN. The MIC3 gene of toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun. 2003;71:6222–8.PubMed CentralPubMedView ArticleGoogle Scholar
- Fang R, Nie H, Wang Z, Tu P, Zhou D, Wang L, et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol. 2009;164:134–40.PubMedView ArticleGoogle Scholar
- Ismael AB, Hedhli D, Cérède O, Lebrun M, Dimier-Poisson I, Mévélec MN. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection. Vaccine. 2009;27:2959–66.PubMedView ArticleGoogle Scholar
- Wu X, Zhang Q, Liu LP, Tan K, Guan JW, Shu HP. The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice. Vet Parasitol. 2009;166:1–7.View ArticleGoogle Scholar
- Hiszczyńska-Sawicka E, Li H, Boyu Xu J, Akhtar M, Holec-Gasior L, Kur J, et al. Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene. Pol J Vet Sci. 2012;15:3–9.PubMedGoogle Scholar
- Ivory C, Chadee K. DNA vaccines: designing strategies against parasitic infections. Genet Vaccines Ther. 2004;2:17–25.PubMed CentralPubMedView ArticleGoogle Scholar
- Wang YH, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasites Vectors. 2014;7:180.PubMed CentralPubMedView ArticleGoogle Scholar
- Qu D, Yu H, Wang S, Cai W, Du A. Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vet Parasitol. 2009;166:220–7.PubMedView ArticleGoogle Scholar
- Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol. 2012;187:140–6.PubMedView ArticleGoogle Scholar
- Qu D, Han J, Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res. 2013;112:2593–9.PubMedView ArticleGoogle Scholar
- Wang YH, Wang M, Wang GX, Pang AN, Fu BQ, Yin H, et al. Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens. Vaccine. 2011;29:8619–23.PubMedView ArticleGoogle Scholar
- Jiang T, Zhou YQ, Nie H, Chen SG, Fang R, Yao BA, et al. Boost effect of interferon-gamma on immunoprotection of Toxoplasma gondii mic3 dna vaccine in mice. J Huazhong Agr Univ. 2007;26:519–23.Google Scholar
- Daryani A, Hosseine AZ, Dalimi A. Immune response against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol. 2003;113:123–34.PubMedView ArticleGoogle Scholar
- Hiramoto RM, Galisteo AJ, do Nascimento N, de Andrade HF. 200Gy sterilized Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice. Vaccine. 2002;20:2072–81.PubMedView ArticleGoogle Scholar
- Jiang T, Gong D, Ma LA, Nie H, Zhou Y, Yao B, et al. Evaluation of a recombinant MIC3 based latex agglutination test for the rapid serodiagnosis of Toxoplasma gondii infection in swines. Vet Parasitol. 2008;158:51–6.PubMedView ArticleGoogle Scholar
- Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol. 2003;4:5414–8.View ArticleGoogle Scholar
- Maksimov P, Zerweck J, Maksimov A, Hotop A, Gross U, Pleyer U, et al. Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans. Clin Vaccine Immunol. 2012;19:865–74.PubMed CentralPubMedView ArticleGoogle Scholar
- Du F, Feng HL, Nie H, Tu P, Zhang QL, Hu M, et al. Survey on the contamination of Toxoplasma gondii oocysts in the soil of public parks of Wuhan, China. Vet Parasitol. 2012;184:141–6.PubMedView ArticleGoogle Scholar
- Du F, Zhang Q, Yu Q, Hu M, Zhou Y, Zhao J. Soil contamination of Toxoplasma gondii oocysts in pig farms in central China. Vet Parasitol. 2012;187:53–6.PubMedView ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.